• Nov 26 2012 NeoStem to Present at Piper Jaffray 24th Annual Healthcare Conference
• Nov 15 2012 NeoStem Ranked Number 1 Fastest Growing Company in the Tri-State Region on Deloitte's 2012 Technology Fast 500(TM)
• Nov 14 2012 NeoStem Announces Quarterly Results and Business Update
• Oct 31 2012 NeoStem to Present at Multiple Conferences in November
• Oct 17 2012 NeoStem Announces the Redemption of the Outstanding 7% Series E Preferred Stock
• Oct 4 2012 NeoStem’s CEO Robin Smith Gives ‘The Stock Radio’ an Update on the Company
• Oct 2 2012 NeoStem to Present at Multiple Conferences in October
• Sep 19 2012 NeoStem to Present at Noble Capital Markets’ Life Sciences Exposition on September 24
• Sep 4 2012 NeoStem to Present at Three Investor Conferences in September
• Aug 14 2012 NeoStem Announces Quarterly Results and Business Update
• Jul 16 2012 NeoStem's Subsidiary, Progenitor Cell Therapy, and SOTIO Enter Into a Phase 3 Manufacturing Services Agreement
• Jul 10 2012 NeoStem to Present at the Seventh Annual JMP Securities Healthcare Conference
• Jul 9 2012 NeoStem CEO's Letter to Shareholders
• Jun 20 2012 NeoStem Announces Webcasting for the Marcum MicroCap Conference on June 20
• May 31 2012 NeoStem to Present at Six Conferences in June
• May 11 2012 NeoStem Reports First Quarter 2012 Results and Provides Business Update
• Apr 18 2012 NeoStem to Present at BioCentury Future Leaders in the Biotech Industry Conference
• Apr 11 2012 NeoStem Announces the Addition of Jonathan Sackner-Bernstein, MD, Past FDA Official, as Vice President, Clinical Development and Regulatory Affairs
• Apr 5 2012 NeoStem Closes Public Offering for $6,800,000 in Gross Proceeds
• Mar 29 2012 NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds

< Prev | 1 | 2 | 3 | Next >